Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

METHYLENE BLUE-ENHANCED BLOOD WASHING DURING ZERO-BALANCE ULTRAFILTRATION REDUCES FLUID OVERLOAD AND INFLAMMATORY RESPONSE FOLLOWING CARDIOPULMONARY BYPASS: A RANDOMIZED CLINICAL TRIAL

NCT07212842 is registered in ClinicalTrials.gov with University of Sao Paulo as lead sponsor.

NCT NCT07212842
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07212842 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
METHYLENE BLUE-ENHANCED BLOOD WASHING DURING ZERO-BALANCE ULTRAFILTRATION REDUCES FLUID OVERLOAD AND INFLAMMATORY RESPONSE FOLLOWING CARDIOPULMONARY BYPASS: A RANDOMIZED CLINICAL TRIAL
Lead sponsor
University of Sao Paulo
Phase
Phase 2
Overall status
Completed
Start date
April 12, 2021
Completion date
March 16, 2024
Enrollment
124 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve surgery, cardiopulmonary bypass surgery, mitral valve surgery, myocardial revascularization surgery with extracorporeal circulation